KAYS — Kaya Holdings, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1530746 ·
Last close
$0.01
Market Cap
$5.39M
52W High
$0.05
52W Low
$0.01
ADV30
5,897
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 5,408 | 5,370 | -269,010 | -8,584,286 | 199,358 | 26,087 | 2,919,815 |
| Jun 2025 | 10,097 | 3,362 | -162,584 | -2,580,318 | 254,430 | 48,146 | 21,541,194 |
| Mar 2025 | 7,052 | 2,082 | -309,538 | -1,636,770 | 197,289 | 50,718 | 18,994,740 |
| Dec 2024 | -23,875 | -17,697 | -183,810 | 1,058,835 | 216,369 | 39,668 | 17,344,501 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-567,268
Investing CF
$27,128
Financing CF
$666,607
CapEx
$-8,372
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.26
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-51,240,493
Inventory
$348
Receivables
—
ST Investments
—
EBIT TTM
$-10,333,655
Pretax Income TTM
$-11,696,242
Interest Exp TTM
$1,362,587
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$26,691
EBITDA
$-1,028,665
Free Cash Flow
$-7,478,111
Enterprise Value
$4,284,279
Total Cash
$26,087
Total Debt
$580,054
Shares Out
686,433,339
Trailing EPS
$-0.10
Book Value
$-0.00
ROE
—
ROA
-277.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 7,134 | -2,022,028 | -2,080,856 | 216,369 | 17,344,501 | — | -993,261 |
| Dec 2023 | 0 | -1,022,745 | 1,609,697 | 215,856 | 15,966,344 | — | -1,045,799 |
| Dec 2022 | 685,379 | -1,711,440 | -3,576,614 | 843,241 | 18,446,982 | — | -918,799 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INBP | INTEGRATED BIOPHARMA INC | $5.35M | $0.17 | — |
| BGMS | Bio Green Med Solution, Inc. | $5.33M | $0.96 | — |
| FBLG | FibroBiologics, Inc. | $5.52M | $1.06 | — |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $5.24M | $0.40 | — |
| RDHL | RedHill Biopharma Ltd. | $5.24M | $1.01 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.